| 0.579 0 (0%) 04-27 17:35 |
|
| Open: | 0.640 |
| High: | 0.640 |
| Low: | 0.579 |
| Pre. close: | 0.579 |
| Volume: | 246,141 |
| Avg. volume: | 196,980 |
| MA (50): | 0.663 |
| MA (200): | 1.306 |
| Year high: | 2.090 |
| Year low: | 0.552 |
| Market cap: | 29(M) |
| EPS: | -1.27 |
| PE ratio: | -0.456 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Tue, 16 Dec 2025
Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 - The Manila Times
Wed, 22 Oct 2025
Nicox Provides First Half 2025 Financial Results - Yahoo Finance
Thu, 04 Sep 2025
Nicox S.A. (EPA:ALCOX): Are Analysts Optimistic? - simplywall.st
Wed, 03 Sep 2025
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed - Yahoo Finance
Wed, 03 Sep 2025
Nicox reports positive phase 3 data on NCX 470 glaucoma eye drop - Eyes On Eyecare
Thu, 21 Aug 2025
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients - GlobeNewswire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.